Vivimed Labs Limited has reported its financial results for the quarter and nine months ended December 31, 2024. The company generated total revenue of ₹908.09 crore, with a profit before tax of ₹(263.61) crore.

Notably, Vivimed has defaulted on loan repayments totaling ₹3,746.40 crore, classified as non-performing assets (NPAs) due to ongoing negotiations with lenders.

This situation may influence investor sentiment negatively, given the financial challenges and interest expenses left unaccounted for, indicating potential operational risks and a need for strategic restructuring to regain stability.